Results 2,881-2,900 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: If builder A has sued me nine times previously, it will probably come into my consideration of what is economically most advantageous.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Why not?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: I would be very interested in a note on why we cannot take such matters into account. I know it is probably a deeper issue but Mr. Barry has unique experience in the area in which we are interested. Is Mr. Barry's relationship with BAM, whether on the State side or the private side, recent?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: What about the private side? I do not mean to pry but it is in the public interest.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Okay, that is fine. I welcome the Secretary General. He said that PwC consultants retain their independence but, as I said earlier, the contestants cannot judge the beauty pageant. By Mr. Breslin's admission PwC threw in a few extra lines at the end to reaffirm their genius in its advices of November or December in the report. Despite the great name and global standing of PwC, can Mr....
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: It is a matter of form that the practice should be not to do these things. I said at the previous meeting we had on this that while it is the prerogative of the Office of Comptroller and Auditor General to decline a request to do particular work, the one thing that we have with the office is absolute certainty that no commercial relationships exist. Was the high-level advice before...
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: That is not a tender though.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: So it went out to tender. How much did PwC get for that? We know it received €450,000 for the later report but how much did it receive for the high-level input before Christmas?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: How much was the company paid?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: No, I made an observation, which I am entitled to do.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: How much did the company receive?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: The company received €21,000 for that. At €55,000 a week that is probably two days.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Why was the steering group not consulted? The steering group met in November and said that it needed another meeting to consider the GMP report in order that it might make a recommendation to the board, which, in turn, could make a recommendation to the Government. There was time to procure the four reports that the Chairman mentioned but the officials did not even go to the steering group.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: No, we did not cover it, actually. What we said was that there was not time.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: How much would the penalty have been?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: We would have had to pay €12 million even though we were not on the hook. The Government could have said that it was not going ahead with this.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Would that not have bought time at a minimum?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: Okay. The Government did a deal for phase A leading BAM to believe it was a shoo-in for phase B. If BAM did not get it, it would get money anyway. Is that correct?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: We did but it was inconclusive. There was not time and people were deferring to one another.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Marc MacSharry: There was not time. We are talking about €800 million.